Table 4 Hazard ratios for death from all-cause and cardiovascular causes according to physical indicators*.
Indicators | Entire cohort | Participants without CVD at baseline | ||||||
---|---|---|---|---|---|---|---|---|
Cardiovascular death | All-cause death | Cardiovascular death | All-cause death | |||||
95% CI | P-value | 95% CI | P-value | 95% CI | P-value | 95% CI | P-value | |
Framingham risk score | ||||||||
ā1-SD increase | 2.7 (1.7ā4.4) | <0.001 | 1.9 (1.5ā2.3) | <0.001 | 1.9 (1.1ā3.4) | 0.024 | 1.6 (1.3ā2.2) | <0.001 |
ā<10% | Reference | Ā | Reference | Ā | Ā | Ā | Ā | Ā |
ā10%ā20% | 2.5 (0.6ā10.4) | 0.213 | 1.7 (0.9ā3.3) | 0.130 | 1.7 (0.3ā8.3) | 0.529 | 2.0 (0.9ā4.2) | 0.086 |
āā„0% | 6.5 (1.8ā23.1) | 0.004 | 3.4 (1.9ā6.1) | <0.001 | 3.0 (0.7ā12.7) | 0.128 | 3.1 (1.5ā6.3) | 0.002 |
High-sensitivity CRPā | ||||||||
ā1-SD increase | 1.7 (1.2ā2.3) | 0.001 | 1.5 (1.3ā1.8) | <0.001 | 1.7 (1.2ā2.5) | 0.007 | 1.4 (1.2ā1.7) | 0.001 |
ā>3.0āmg/lā”§ | 3.4 (1.4ā8.3) | 0.008 | 2.6 (1.6ā4.3) | <0.001 | 3.0 (0.9ā10.2) | 0.077 | 2.1 (1.1ā3.8) | 0.02 |
Dominant handgrip strengthā | ||||||||
ā1-SD increase | 0.4 (0.2ā0.8) | 0.004 | 0.4 (0.3ā0.6) | <0.001 | 0.4 (0.2ā0.8) | 0.007 | 0.4 (0.3ā0.6) | <0.001 |
ā<14.3ākg women, <22.4ākg menā” | 4.3 (1.6ā11.3) | 0.004 | 3.8 (2.2ā6.5) | <0.001 | 7.3 (2.0ā26.8) | 0.003 | 5.2 (2.7ā10.0) | <0.001 |
ā<16.0ākg women <28.0ākg men§ | 4.2 (1.5ā11.5) | 0.006 | 3.1 (1.8ā5.4) | <0.0001 | 8.5 (2.2ā32.2) | 0.002 | 4.1 (2.1ā7.9) | <0.0001 |
Relative handgrip strength* | ||||||||
ā1-SD increase | 0.5 (0.3ā0.8) | 0.006 | 0.5 (0.3ā0.6) | <0.001 | 0.4 (0.2ā0.8) | 0.006 | 0.4 (0.3ā0.6) | <0.001 |
ā<0.79 women, <1.32 menā” | 1.1 (0.1ā8.6) | 0.914 | 2.3 (1.0ā5.2) | 0.050 | 0.0 (0.0āNR) | 0.995 | 2.4(0.8ā7.1) | 0.121 |
ā<1.40 women, <2.34 men§ | 3.4 (1.2ā9.5) | 0.017 | 3.9 (2.2ā7.0) | <0.0001 | 6.3 (1.5ā26.1) | 0.011 | 4.6(2.3ā9.2) | <0.0001 |
Walking speedā | ||||||||
ā1-SD increase | 0.7 (0.4ā1.2) | 0.179 | 0.8 (0.6ā1.1) | 0.110 | 0.7 (0.3ā1.5) | 0.313 | 0.8(0.6ā1.2) | 0.293 |
ā<0.8ām/sā”,§ | 1.0 (0.3ā2.7) | 0.925 | 1.2 (0.7ā2.1) | 0.526 | 0.8 (0.2ā3.3) | 0.734 | 1.3(0.6ā2.5) | 0.526 |
Peak expiratory flowā | ||||||||
ā1-SD increase | 0.4 (0.2ā0.8) | 0.011 | 0.5 (0.4ā0.7) | <0.001 | 0.4 (0.2ā0.9) | 0.037 | 0.5(0.4ā0.8) | 0.003 |
ā<250.0āl/minā”,§ | 3.2 (1.2ā8.5) | 0.023 | 2.7 (1.6ā4.7) | 0.0003 | 3.3 (0.8ā13.5) | 0.104 | 2.6(1.3ā5.1) | 0.005 |